Concepedia

M. Golam Mohi

MG

11

Publications

1.8K

Citations

11

H-Index

1998

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Harvard University

The University of Tokyo

M. Golam Mohi is an author at Beth Israel Deaconess Medical Center specializing in medicine, cell biology, and cell signaling.

Top concepts

MedicineCell BiologyCell SignalingApoptosisSystems BiologyMolecular BiologyMolecular SignalingSignal TransductionHealthGenetics

Publications per year

1998–2010

11

Publications

11

Mouse model of Noonan syndrome reveals cell type– and gene dosage–dependent effects of Ptpn11 mutation

Toshiyuki Araki, M. Golam Mohi, Fraz A. Ismat et al. · Nature Medicine · 2004 · 417 citations

Ptpn11 Mutation, Genetic Disorder, Genetics +8

Critical role for Gab2 in transformation by BCR/ABL

Martin Sattler, M. Golam Mohi, Yuri B. Pride et al. · Cancer Cell · 2002 · 358 citations · Full text

Ab-initio Method, Critical Role, Molecular Biology

Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations

M. Golam Mohi, Ifor R. Williams, Charles R. Dearolf et al. · Cancer Cell · 2005 · 275 citations · Full text

Knockout Mouse, Genome Instability, Signal Transduction +7

Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera–like disease

Hajime Akada, Dongqing Yan, Haiying Zou et al. · Blood · 2010 · 243 citations · Full text

Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs

M. Golam Mohi, Christina Boulton, Ting‐Lei Gu et al. · Proceedings of the National Academy of Sciences · 2004 · 239 citations · Full text

Ptk Inhibitor/rapamycin Combinations, Mixed-phenotype Acute Leukemia, Mtor Inhibitor Rapamycin +16

Rows per page

1–5 of 11